Impact of SARS-CoV-2 variants and vaccination on pediatric febrile seizures: a retrospective cohort study

This study aimed to investigate the associations between SARS-CoV-2 variants, inflammatory markers, vaccination history, and demographic characteristics in relation to the occurrence of febrile seizures (FS) in pediatric patients at a single tertiary medical center. Retrospective cohort data were collected from a pediatric tertiary care institution between April 2020 and January 2023, encompassing 339 patients with PCR-confirmed SARS-CoV-2 infections. The cohort was separated into FS (n = 102) and control (n = 237) groups. A multivariable logistic regression analysis was employed to evaluate the impact of viral variants (Delta and Omicron sublineages), inflammatory markers (IL-6, D-dimer, CRP), vaccination status (unvaccinated, partially vaccinated, fully vaccinated), and demographic variables, while controlling for potential confounders. The incidence of FS among infants under one year of age was found to be 41.2%, in contrast to 17.7% in older children (OR = 3.2, 95% CI: 1.8–5.7; P < 0.001). Elevated levels of IL-6 exceeding 10 pg/mL and D-dimer levels surpassing 0.5 mg/L were independently associated with an increased risk of recurrent FS (adjusted OR [aOR] = 2.8 and 2.1, respectively), as well as a 3.1-fold increase in the risk of recurrence. Full vaccination was linked to a 68% reduction in FS risk (aOR = 0.32, 95% CI: 0.18–0.55), particularly benefiting infants. Additionally, male infants exhibited a 1.8-fold increased vulnerability (P = 0.016). Omicron sublineages (BA.5/XBB), which accounted for 78.4% of FS cases, correlated with heightened biomarker levels. The findings suggest that IL-6 and D-dimer serve as valuable indicators for assessing the risk of FS in children infected with SARS-CoV-2. The association of vaccination with reduced FS risk suggests potential protective effects, highlighting greater susceptibility among male infants. • Patients with FS had significantly higher IL-6 (> 10 pg/mL) and D-dimer (> 0.5 mg/L) levels than controls. These elevations were associated with an increased risk of recurrent FS. • Fully vaccinated children had a 68% lower incidence of FS compared to unvaccinated children. • Male infants showed higher FS incidence (41.2%), consistent with established demographic patterns.

Authors

Institutions

Publication Details

Journal
BMC Pediatrics
Published
2025-11-13
DOI
https://doi.org/10.1186/s12887-025-06095-5
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of SARS-CoV-2 variants and vaccination on pediatric febrile seizures: a retrospective cohort study

Y Wang, Caijin Yan, Mei Yang, Jing Gao et al.
BMC Pediatrics
Epilepsy research and treatment
article

Impact of SARS-CoV-2 variants and vaccination on pediatric febrile seizures: a retrospective cohort study

Y Wang, Caijin Yan, Mei Yang, Jing Gao, Gangxi Lin, Chong Yao
article en

Abstract

This study aimed to investigate the associations between SARS-CoV-2 variants, inflammatory markers, vaccination history, and demographic characteristics in relation to the occurrence of febrile seizures (FS) in pediatric patients at a single tertiary medical center. Retrospective cohort data were collected from a pediatric tertiary care institution between April 2020 and January 2023, encompassing 339 patients with PCR-confirmed SARS-CoV-2 infections. The cohort was separated into FS (n = 102) and control (n = 237) groups. A multivariable logistic regression analysis was employed to evaluate the impact of viral variants (Delta and Omicron sublineages), inflammatory markers (IL-6, D-dimer, CRP), vaccination status (unvaccinated, partially vaccinated, fully vaccinated), and demographic variables, while controlling for potential confounders. The incidence of FS among infants under one year of age was found to be 41.2%, in contrast to 17.7% in older children (OR = 3.2, 95% CI: 1.8–5.7; P < 0.001). Elevated levels of IL-6 exceeding 10 pg/mL and D-dimer levels surpassing 0.5 mg/L were independently associated with an increased risk of recurrent FS (adjusted OR [aOR] = 2.8 and 2.1, respectively), as well as a 3.1-fold increase in the risk of recurrence. Full vaccination was linked to a 68% reduction in FS risk (aOR = 0.32, 95% CI: 0.18–0.55), particularly benefiting infants. Additionally, male infants exhibited a 1.8-fold increased vulnerability (P = 0.016). Omicron sublineages (BA.5/XBB), which accounted for 78.4% of FS cases, correlated with heightened biomarker levels. The findings suggest that IL-6 and D-dimer serve as valuable indicators for assessing the risk of FS in children infected with SARS-CoV-2. The association of vaccination with reduced FS risk suggests potential protective effects, highlighting greater susceptibility among male infants. • Patients with FS had significantly higher IL-6 (> 10 pg/mL) and D-dimer (> 0.5 mg/L) levels than controls. These elevations were associated with an increased risk of recurrent FS. • Fully vaccinated children had a 68% lower incidence of FS compared to unvaccinated children. • Male infants showed higher FS incidence (41.2%), consistent with established demographic patterns.

BMC PediatricsVol. 25(1)
Fujian Medical University (CN), First Affiliated Hospital of Xiamen University (CN)
Xiamen University
Openalex Percentile: Top 60%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.